EU Panel Says Contraceptive Benefits Outweigh Clot Risks

Law360, New York (October 11, 2013, 2:44 PM EDT) -- The European Medicines Agency said Friday that the benefits to women of using combined hormonal contraceptives outweigh the risks of blood clots, and there is no reason for women who have been using them with no problem to discontinue their use.

The EMA’s Pharmacovigilance Risk Assessment Committee said it reviewed the risk of venous thromboembolism, or blood clots in veins, with combined hormonal contraceptives and concluded that the benefits of CHCs at preventing unwanted pregnancies outweigh their risks.

“It is important that women are made aware...
To view the full article, register now.